Skip to content

Investor Relations / SEC Filings

SEC Filings

Filing date Form Filer Description View
4 Salyer Marc

Statement of changes in beneficial ownership of securities

View HTML
4 THERO JOHN F

Statement of changes in beneficial ownership of securities

View HTML
8-K

Report of unscheduled material events or corporate event

View HTML
424B5

Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3

View HTML
424B5

Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3

View HTML
4 Ketchum Steven B

Statement of changes in beneficial ownership of securities

View HTML
4 KENNEDY JOSEPH T

Statement of changes in beneficial ownership of securities

View HTML
4 Ketchum Steven B

Statement of changes in beneficial ownership of securities

View HTML
4 Ketchum Steven B

Statement of changes in beneficial ownership of securities

View HTML
8-K

Report of unscheduled material events or corporate event

View HTML

Copyright Morningstar

copyright
© 2018, Amarin Corporation
Privacy policy  |  Disclaimer
Dublin Office
2 Pembroke House, Upper Pembroke
Street 28-32
Dublin 2, Ireland
US Investor Relations
Amarin Pharma Inc.
1430 Route 206
Bedminster, NJ 07921 USA
Telephone:
+1 908 719 1315
Fax:
+1 908 719 3012

Amarin Corporation